By Counterforce Health Team in Ocrevus (ocrelizumab) —

Myths vs. Facts: Getting Ocrevus (ocrelizumab) Covered by Aetna (CVS Health) in Florida

Answer Box: Getting Ocrevus Covered by Aetna in Florida

Eligibility: Aetna covers Ocrevus for relapsing MS and primary progressive MS when prescribed by or in consultation with a neurologist. Fastest path: Submit complete prior authorization at least 2 weeks before treatment with MS diagnosis confirmation, prior therapy documentation, and hepatitis B screening. First step today: Contact your neurologist to request the Aetna Ocrevus precertification form and gather your complete treatment history from all providers.

Table of Contents

  1. Why Myths About Ocrevus Coverage Persist
  2. Myth vs. Fact: Common Misconceptions
  3. What Actually Influences Approval
  4. Avoid These Preventable Mistakes
  5. Quick Action Plan: Three Steps to Take Today
  6. Appeals Process in Florida
  7. FAQ
  8. Resources

Why Myths About Ocrevus Coverage Persist

When facing a multiple sclerosis diagnosis, patients and families often rely on outdated information, anecdotal experiences, or well-meaning advice that doesn't reflect current insurance realities. With Ocrevus costing tens of thousands annually, these misconceptions can lead to unnecessary delays, denials, or out-of-pocket expenses.

The complexity of Aetna's coverage policies—which vary by plan type, state regulations, and recent policy changes—creates fertile ground for myths. As of July 2025, Ocrevus moved to pharmacy-only coverage under many Aetna commercial plans, adding another layer of confusion for patients navigating the system.

Understanding the facts can mean the difference between quick approval and months of appeals. Let's separate myth from reality.

Myth vs. Fact: Common Misconceptions

Myth 1: "If my neurologist prescribes Ocrevus, Aetna automatically covers it"

Fact: Aetna requires prior authorization for Ocrevus regardless of your doctor's recommendation. Your neurologist must submit a precertification request at least two weeks before treatment, including complete clinical documentation and justification for medical necessity.

Myth 2: "I need to try cheaper MS drugs first before Aetna will cover Ocrevus"

Fact: Aetna does not require step therapy for Ocrevus when prescribed for FDA-approved MS indications. However, you may need to document why other treatments failed or are inappropriate for your specific case, especially if requesting a formulary exception.

Myth 3: "Appeals take forever and rarely succeed"

Fact: Approximately 82% of Medicare Advantage appeals for Ocrevus that proceed through multiple levels eventually succeed. The key is persistence and proper documentation. In Florida, you have well-defined timelines: 30 days for standard appeals, 72 hours for expedited appeals when your health is at risk.

Myth 4: "My plan covers MS drugs, so Ocrevus should be included"

Fact: Coverage varies significantly by plan design. Some Aetna plans may exclude Ocrevus entirely, place it on a high-cost tier, or require specific documentation. Check your plan's formulary and understand your specific coverage details before assuming approval.

Myth 5: "I can't appeal if my doctor didn't fight the first denial"

Fact: You have independent appeal rights in Florida regardless of your doctor's involvement. Florida law requires insurers to provide at least one level of internal appeal, and you can pursue external review through the state if internal appeals fail.

Myth 6: "Aetna won't cover Ocrevus for primary progressive MS"

Fact: Aetna explicitly covers Ocrevus for primary progressive MS when prescribed by or in consultation with a neurologist. Authorization of 12 months may be granted for members with confirmed primary progressive MS diagnosis.

Myth 7: "If I get denied, I should just pay out of pocket"

Fact: Before paying thousands out of pocket, explore all options. Request a peer-to-peer review, file an appeal, check for manufacturer assistance programs, or work with Counterforce Health to build a stronger case with evidence-backed documentation.

What Actually Influences Approval

Understanding Aetna's actual decision-making process helps you submit winning requests from the start.

Core Approval Criteria

Medical Necessity Requirements:

  • MS diagnosis confirmed by a neurologist
  • Specific MS phenotype documented (relapsing-remitting, secondary progressive with relapses, or primary progressive)
  • Clinical justification for Ocrevus over alternatives

Documentation Standards:

  • Complete precertification form with all fields completed
  • MRI reports demonstrating MS lesions
  • Prior therapy history from all providers
  • Hepatitis B screening results and complete blood count
  • Medical necessity letter from your neurologist

Coverage Routing Factors

Plan Type Considerations:

  • Commercial plans: Pharmacy benefit through CVS Caremark
  • Medicare Advantage: Medical benefit with specific quantity limits
  • Medicaid: State-specific formulary requirements

Geographic Factors in Florida:

  • Florida's external review process through independent review organizations
  • State-specific appeal timelines and consumer protections
  • Access to Florida Department of Financial Services assistance

Avoid These Preventable Mistakes

1. Incomplete Initial Submissions

The Problem: Missing required documentation leads to automatic denials that could have been avoided.

The Fix: Use Aetna's official precertification checklist and submit all required pages. Verify your neurologist's office has your complete treatment history before submission.

2. Wrong Submission Timeline

The Problem: Submitting less than two weeks before treatment can delay approval and force treatment postponement.

The Fix: Plan ahead. Start the prior authorization process immediately after your neurologist recommends Ocrevus, not when you're ready to schedule infusions.

3. Inadequate Medical Necessity Letters

The Problem: Generic letters that don't address Aetna's specific criteria or explain why Ocrevus is uniquely necessary for your case.

The Fix: Request that your neurologist specifically address Aetna's medical necessity criteria and explain why alternative treatments are inappropriate or have failed.

4. Not Requesting Peer-to-Peer Reviews

The Problem: Accepting initial denials without utilizing Aetna's peer-to-peer review process, where success rates are significantly higher.

The Fix: Immediately request a peer-to-peer review upon any denial. These physician-to-physician conversations often resolve coverage issues within 5-10 days.

5. Ignoring Plan-Specific Requirements

The Problem: Assuming all Aetna plans have identical coverage when requirements vary significantly by plan design and state.

The Fix: Review your specific plan's formulary and coverage policies. Contact Aetna member services to confirm your plan's exact requirements for Ocrevus coverage.

Quick Action Plan: Three Steps to Take Today

Step 1: Gather Essential Documentation (30 minutes)

What You Need:

  • Insurance card with member ID and group number
  • Complete list of all MS medications you've tried (names, dates, outcomes)
  • Contact information for all neurologists and MS specialists you've seen
  • Recent MRI reports and lab results

Action: Create a folder (physical or digital) with copies of all MS-related medical records from the past 2-3 years.

Step 2: Contact Your Neurologist's Office (15 minutes)

What to Say: "I need to start prior authorization for Ocrevus through Aetna. Can you send me the current precertification form and confirm what documentation you'll need from me?"

Follow-up: Ask specifically about their timeline for completing the medical necessity letter and submitting the prior authorization.

Step 3: Verify Your Coverage Details (20 minutes)

Call Aetna Member Services: Use the number on your insurance card to confirm:

  • Whether Ocrevus requires prior authorization under your specific plan
  • Your plan's formulary tier for Ocrevus
  • Whether you need to use CVS Specialty Pharmacy
  • Your expected copay or coinsurance amount

Document Everything: Write down the representative's name, date, and all information provided for future reference.

Appeals Process in Florida

If your initial prior authorization is denied, Florida provides multiple levels of appeal with specific consumer protections.

Internal Appeal Timeline

Standard Appeals:

  • File within: 60 days of denial notice
  • Aetna's decision timeline: 30 days
  • Required documentation: Denial letter, additional clinical evidence, updated medical necessity letter

Expedited Appeals:

  • When to use: If waiting 30 days would harm your health
  • File within: 60 days of denial notice
  • Aetna's decision timeline: 48-72 hours
  • Required: Physician certification that delay poses health risk

External Review Process

If Aetna upholds the denial after internal appeal, Florida provides independent external review:

Timeline: Request within 120 days of final internal appeal decision Process: Contact Florida Department of Financial Services at 1-877-MY-FL-CFO (877-693-5236) Cost: No charge to consumers Decision: Binding on Aetna if reviewer determines coverage is medically necessary

From our advocates: We've seen cases where patients received denials for "experimental" treatment, only to have external reviewers overturn the decision within weeks by citing FDA approval and established clinical guidelines. The key was submitting comprehensive documentation that clearly demonstrated medical necessity according to published standards.

FAQ

Q: How long does Aetna prior authorization take for Ocrevus in Florida? A: Standard prior authorization decisions typically take 30 days, but can be expedited to 72 hours if your physician certifies that delays would pose health risks. Submit at least two weeks before your planned treatment date.

Q: What if Ocrevus is not on my Aetna formulary? A: You can request a formulary exception by documenting that preferred alternatives have failed, caused intolerable side effects, or are contraindicated for your specific case.

Q: Can I use manufacturer copay assistance with Aetna? A: Copay assistance eligibility varies by plan type. Commercial insurance members may qualify for Genentech's copay program, but Medicare and Medicaid beneficiaries typically cannot use manufacturer assistance due to federal regulations.

Q: What happens if I need Ocrevus urgently? A: Request an expedited appeal if you face immediate health risks from treatment delays. Your neurologist must certify the urgent medical need, and Aetna must respond within 72 hours.

Q: Does step therapy apply if I've tried other MS drugs outside Florida? A: Yes, prior treatment history from any location counts toward meeting step therapy requirements. Ensure your neurologist includes complete documentation of all previous MS treatments and their outcomes.

Q: Who can help if I'm overwhelmed by the appeals process? A: Counterforce Health specializes in turning insurance denials into successful appeals by creating evidence-backed documentation that addresses specific payer requirements. You can also contact Florida's Insurance Consumer Helpline at 1-877-MY-FL-CFO for assistance navigating the process.

Resources

Official Aetna Forms and Policies

Florida Insurance Resources

Clinical and Manufacturer Resources

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage policies change frequently. Always verify current requirements with Aetna directly and consult your healthcare provider for medical decisions. For assistance with complex appeals, consider working with Counterforce Health, which helps patients and clinicians build evidence-backed appeals that address specific payer requirements and improve approval rates.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.